Search
Two pivotal studies published in the New England Journal of Medicine and conducted by Memorial Sloan Kettering researchers offer proof of better treatment options for patients with advanced renal cell carcinoma (RCC), the most common form of kidney cancer.
Catch up with some of the patients we got to know in 2017.
At Memorial Sloan Kettering Cancer Center, more than half of patients with gallbladder cancer are diagnosed incidentally following elective cholecystectomy for assumed benign disease. The traditional treatment approach for these patients is re-resection to achieve a cure.
Medical oncologist Mark Kris discusses how new guidelines for preventing nausea and vomiting due to treatment can improve quality of life for people with cancer.
Memorial Sloan Kettering’s annual seminar exposes high school students and their teachers to cutting-edge scientific research.
philanthropist and art collector Iris Cantor has made a major commitment to Memorial Sloan Kettering Cancer Center to create an endowed chair for a senior researcher in the field of digestive cancers.
Take a look back at some of the biggest cancer science stories from this past year.
A team of experts at Memorial Sloan Kettering shared their insights on prostate cancer and men’s health in an Information Session for patients, caregivers and those at increased risk for the disease.
The largest study of its kind to look at data from children with cancer finds inherited cancer genes are more common than expected.